You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 31722-0865


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 31722-0865

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC: 31722-0865 (Linezolid by Camber Pharmaceuticals)

Overview of Linezolid

Linezolid, with the NDC code 31722-0865, is an antibiotic medication manufactured by Camber Pharmaceuticals, Inc. It is used to treat various bacterial infections, including those caused by antibiotic-resistant bacteria such as MRSA (methicillin-resistant Staphylococcus aureus)[5].

Market Context

The pharmaceutical market, particularly the segment involving antibiotics like Linezolid, is influenced by several factors:

Growth of the Pharmaceutical Market

The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].

Generic Drug Market

Generic drugs, such as those produced by Camber Pharmaceuticals, play a crucial role in this growth. The approval and production of generic drugs have increased, contributing to the overall market expansion. However, the prices of generic drugs can be volatile, with some experiencing significant price increases. For instance, a generic version of naproxen saw a 2,527% price increase between 2012 and 2021[2].

Price Trends and Projections

Historical Pricing

While specific historical pricing data for Linezolid (NDC: 31722-0865) is not provided, the broader trend in generic drug pricing is relevant. Generic drugs have seen median price increases, with a reported median increase of 19.9% in 2022[2].

Regulatory and Transparency Efforts

Efforts to enhance price transparency, such as those in Oregon, require manufacturers to report price increases and provide detailed information on the reasons behind these increases. This transparency can help in understanding and potentially regulating price hikes. However, the effectiveness of these measures in controlling prices is still being evaluated[2].

Upper Payment Limits

Some states are considering the implementation of upper payment limits for certain drugs, which could impact the pricing of medications like Linezolid. This approach, similar to pharmaceutical rate setting in other countries, aims to make drugs more affordable but has not yet been tested in practice[2].

Factors Influencing Price

Supply Chain Dynamics

The price of prescription drugs, including Linezolid, is influenced by interactions and financial negotiations within the pharmaceutical supply chain. This includes interactions between manufacturers, pharmacy benefit managers (PBMs), health insurers, and other entities. Understanding these dynamics is crucial for developing policies to address price transparency and affordability[2].

Technological Advancements

The increasing adoption of AI-based tools in drug discovery and development could impact the cost structure of pharmaceutical companies. While AI can streamline processes and reduce costs in the long run, the initial investment in these technologies might temporarily affect pricing strategies[4].

Regulatory Landscape

Evolving regulatory frameworks, particularly those related to clinical trial designs and approval processes, can influence the cost and pricing of drugs. More efficient clinical trials and regulatory approvals can reduce development costs, potentially leading to more competitive pricing[3].

Price Projections

Given the current trends and factors influencing the pharmaceutical market:

  • Short-Term Projections: In the short term, the price of Linezolid (NDC: 31722-0865) may see moderate increases, aligning with the median price increase for generic drugs. However, significant hikes like those seen in other generic drugs are possible but less likely without specific market disruptions.

  • Long-Term Projections: Over the long term, the price could stabilize or decrease as regulatory efforts to enhance transparency and control costs take effect. Additionally, advancements in technology and more efficient clinical trial designs could reduce development and production costs, leading to more competitive pricing.

Key Takeaways

  • The US pharmaceutical market, including generic drugs like Linezolid, is expected to grow significantly.
  • Price transparency and regulatory efforts are crucial in understanding and controlling drug prices.
  • Technological advancements and evolving regulatory landscapes can impact the cost and pricing of drugs.
  • Short-term price projections may include moderate increases, while long-term projections suggest potential stabilization or reduction in prices.

FAQs

Q: What is Linezolid used for? A: Linezolid is an antibiotic used to treat various bacterial infections, including those caused by antibiotic-resistant bacteria.

Q: Who manufactures Linezolid with the NDC code 31722-0865? A: Camber Pharmaceuticals, Inc. manufactures Linezolid with the NDC code 31722-0865.

Q: What are the key factors influencing the price of Linezolid? A: The price of Linezolid is influenced by supply chain dynamics, regulatory efforts, technological advancements, and overall market trends.

Q: Are there any regulatory efforts to control the price of generic drugs like Linezolid? A: Yes, several states, including Oregon, have implemented policies to enhance price transparency and are considering measures like upper payment limits to control drug prices.

Q: How might technological advancements impact the price of Linezolid? A: Technological advancements, such as the use of AI in drug discovery, could reduce development and production costs in the long term, potentially leading to more competitive pricing.

Sources

  1. FindACode: Camber Pharmaceuticals, Inc. - List of Drugs - NDC Labeler.
  2. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations.
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
  5. FindACode: Camber Pharmaceuticals - List of Drugs - NDC Labeler/Manufacturer.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.